Athira Pharma Stock (NASDAQ: ATHA) stock price, news, charts, stock research, profile.
Open | $2.150 |
Close | $2.120 |
Volume / Avg. | 80.804K / 348.887K |
Day Range | 2.105 - 2.205 |
52 Wk Range | 1.330 - 4.298 |
Market Cap | $81.253M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 3.88% |
Days to Cover | 4.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Athira Pharma (NASDAQ: ATHA) through any online brokerage.
Other companies in Athira Pharma’s space includes: SCYNEXIS (NASDAQ:SCYX), Jaguar Health (NASDAQ:JAGX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP) and Marinus Pharma (NASDAQ:MRNS).
The latest price target for Athira Pharma (NASDAQ: ATHA) was reported by JMP Securities on Friday, August 11, 2023. The analyst firm set a price target for 19.00 expecting ATHA to rise to within 12 months (a possible 796.23% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Athira Pharma (NASDAQ: ATHA) is $2.12 last updated May 8, 2024 at 4:29 PM EDT.
There are no upcoming dividends for Athira Pharma.
Athira Pharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Athira Pharma.
Athira Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.